Page last updated: 2024-12-07
rugulovasine b
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
rugulovasine B: from P. concavo-rugulosum Abe, P. islandicum, P. rubrum & P. biforme; RN given refers to (trans-(+-))-isomer; see also rugulovasine A, (trans-(+-))-isomer: 26909-33-1; structure in Merck Index, 9th ed, #8053 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 119088 |
| MeSH ID | M0088414 |
Synonyms (11)
| Synonym |
|---|
| 26909-34-2 |
| rugulovasine b |
| spiro(benz(cd)indole-5(1h),2'(5'h)-furan)-5'-one, 3,4-dihydro-4'-methyl-4-(methylamino)-, trans-(+-)- |
| unii-0e5879r1wv |
| spiro(benz(cd)indole-5(1h),2'(5'h)-furan)-5'-one, 3,4-dihydro-4'-methyl-4-(methylamino)-, (2'r,4r)-rel- |
| 0e5879r1wv , |
| rugulovasine b [mi] |
| spiro(benz(cd)indole-5(1h),2'(5'h)-furan)-5'-one, 3,4-dihydro-4'-methyl-4-(methylamino)-, trans- |
| spiro(benz(cd)indole-5(1h),2'(5'h)-furan)-5'-one, 3,4-dihydro-4'-methyl-4-(methylamino)-, trans-(+/-)- |
| Q27236662 |
| DTXSID901046325 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (3)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||